Provided by Tiger Trade Technology Pte. Ltd.

Axsome Therapeutics

184.39
-1.7500-0.94%
Post-market: 184.390.00000.00%19:30 EDT
Volume:1.03M
Turnover:191.41M
Market Cap:9.66B
PE:-48.93
High:188.00
Open:186.51
Low:184.00
Close:186.14
52wk High:260.19
52wk Low:117.30
Shares:52.38M
Float Shares:43.83M
Volume Ratio:1.17
T/O Rate:2.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7685
EPS(LYR):-3.6821
ROE:-245.10%
ROA:-16.31%
PB:115.94
PE(LYR):-50.08

Loading ...

Axsome Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 10

Sector Update: Healthcare Stocks Edge Higher Premarket Monday

MT Newswires Live
·
Aug 10

Axsome Therapeutics Shares Reverse Course Premarket; Last up 2.2%

THOMSON REUTERS
·
Aug 10

Heron Therapeutics Q2 Revenue Rises on Acute Care Growth, Withdraws 2026 Outlook

Reuters
·
Aug 10

CervoMed Q2 Net Loss Lower than Estimates as Costs Drop

Reuters
·
Aug 10

Axsome Therapeutics reports Q2 EPS (99c), consensus (85c)

TIPRANKS
·
Aug 10

Axsome Therapeutics Q2 Loss Widens, Revenue Increases

MT Newswires Live
·
Aug 10

Axsome Therapeutics Q2 Revenue Rises on Auvelity Growth

Reuters
·
Aug 10

Axsome Therapeutics Shares Down 8.4% Premarket After Q2 Revenue Miss

THOMSON REUTERS
·
Aug 10

Axsome Q2 FY26 Net Loss Widens to $51.3 Million; Net Product Revenue Climbs 46% to $218.4 Million Year over Year

Reuters
·
Aug 10

Stock Track | Axsome Therapeutics Plunges 5.99% in Pre-market After Q2 Earnings Miss Estimates

Stock Track
·
Aug 10

Earnings Flash (AXSM) Axsome Therapeutics Posts Q2 Loss $0.99 a Share, vs. FactSet Est of $0.89 Loss

MT Newswires Live
·
Aug 10

Axsome Therapeutics Q2 EPS $(0.99) Misses $(0.83) Estimate, Sales $218.400M Miss $221.230M Estimate

Benzinga Earnings
·
Aug 10

Axsome Therapeutics Q2 Net Income USD -51.314 Million

Reuters
·
Aug 10

Axsome Therapeutics Q2 EPS USD -0.99

THOMSON REUTERS
·
Aug 10

Axsome Therapeutics Q2 Operating Expenses USD 268.021 Million

THOMSON REUTERS
·
Aug 10

Axsome Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
Aug 10

Axsome Therapeutics (AXSM) Could Be 25% Undervalued As CNS Pipeline Hopes Build

Simply Wall St.
·
Aug 10

Axsome CEO Herriot Tabuteau Disposes of USD 10.54 Million in Common Shares

Reuters
·
Aug 08

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 07